Retatrutide: The Complete Stability Picture

Retatrutide is an investigational GIP / GLP-1 / glucagon triple agonist,¹ and it has been through more extended-duration stability testing than any other compound in our library. Eight dedicated studies tested it under refrigeration, room temperature, freezing, freeze-thaw cycling, sustained 130 °F heat, and bacteriostatic versus ultrapure water.

No single study answers “how stable is retatrutide,” because each was designed for a different question, with different intervals, conditions, and vendors. Together they do. This article puts them in one place, with every study design named so you can see what produced each number.

Here is the summary by condition, before the detail:

Why we read mass, not purity, for stability

One methodological point shapes everything below. Before a sample is run, the lab filters it to protect the instrument, and that filter removes insoluble material, including the aggregates a peptide forms as it degrades. The purity number therefore reflects only what stayed in solution and passed the filter. Labs flag this directly on the certificate of analysis:

The purity is elevated due to the removal of insoluble degradation products by filtration.

So a solution can shed peptide to aggregation and still report a high purity, because the degraded material was filtered out before the reading. For stability over time we therefore lead with mass (total recovered peptide), which captures that loss, and treat a high purity as necessary but not sufficient. Depending on the test, that quantity is reported as recovered mass or as total peptide (mass × purity); both track how much peptide is present, and both fall as it is lost. Purity is still the right readout for the dry powder, where degradation is chemical rather than aggregation, but for a solution in storage, watch the mass.

Reconstituted and refrigerated: the practical answer

The most common practical question: once it’s mixed, how long does it last in the fridge?

We have four refrigerated reconstituted datasets that answer it, using bacteriostatic water as the diluent.

Here, refrigerated means controlled laboratory storage, not a home fridge: when a study design calls for a reconstituted sample to be held refrigerated for a set period, Janoshik keeps it in a laboratory-grade refrigerator at a constant 4 °C. Every reconstituted sample held refrigerated in this article reflects that steady 4 °C, without the temperature swings of a household door being opened and closed.

On mass, the chart above tells the story directly: the well-behaved vials drift down modestly, from a couple percent up to about ten, while one SSA vial collapses to 56% of its day-0 mass (the outlier, covered below). Purity looks calmer still, the J5-ZYH and SSA 30 mg vials held above 99.4% and the TCI and XYX vials settled near 97%, but per the filtration caveat above, purity alone flatters an aqueous sample. Mass is the better answer to the shelf-life question.

Test 616 makes the divergence concrete. Its GBBB-ZJC vials lost about 9% of their recoverable mass over 90 days while purity sat near 99.6%. Because the lab filters out insoluble degradation products before the purity reading, that missing 9% is best read as real loss, peptide that aggregated and was filtered away or adsorbed to the vial, rather than waved off because the purity looked pristine. For the practical question of “is it still good after a month or two in the fridge,” the answer here is still yes: the mass decline was slow and modest, single digits over 60 to 90 days. Just judge it by the mass, not the purity.

The diluent matters: bacteriostatic versus ultrapure water

Test 683 is the best-controlled experiment here. Two vials from a single J5-ZYH 60 mg kit were reconstituted side by side: one with Hospira bacteriostatic water, one with ultrapure (preservative-free) water. Both went in the same fridge and were tested on the same days.

Same compound, same kit, same fridge, same days. The only variable was the diluent, and the ultrapure-water sample lost roughly three times as much peptide. The benzyl alcohol in bacteriostatic water is there as a preservative, but here it also tracked with better peptide retention. The practical point: reconstitute with real bacteriostatic water.

Room temperature: usable, but it degrades faster

Test 715 left two products (J5-ZYH 60 mg and QSC 15 mg), reconstituted in bacteriostatic water, at room temperature for 45 days.

Room temperature degrades it faster, and how much depends on the product: one barely moved, the other lost nearly 9% in six weeks. Watch mass rather than purity here, because the purity readings swung too widely to trust (one vial read 95.7% at day 28, then 99.5% at day 45). A few weeks at room temperature is not a disaster, but the fridge is the better default.

Freezing the reconstituted solution did not help

A common instinct is that if the fridge is good, the freezer must be better. For the reconstituted solution, this data says otherwise.

Tests 616 and 624 used the same GBBB-ZJC 60 mg product by design, which makes them directly comparable:

The frozen vials lost 13 to 14% of their mass in 45 days, while the refrigerated vials of the same product lost only 9 to 10% in twice the time. Purity stayed high in every vial (roughly 99.5% throughout), which is exactly what the filtration caveat predicts: peptide that came out of solution as aggregate was filtered off before the reading, so the loss registers as mass, not purity. Whether it aggregated (a form of degradation) or adsorbed to the vial, mass is what tracks it, and freezing lost more, faster.

One important boundary on this finding: it is specifically about freezing the reconstituted solution. Freezing the dry, lyophilized powder is a different question, and as a powder retatrutide is extremely durable.

When it goes wrong: the SSA outlier

Everything above describes a durable, well-behaved compound. Test 473 is the exception: one of three refrigerated vials failed badly.

The TCI and XYX vials behaved like every other refrigerated sample here. The SSA vial collapsed: by day 90, stored identically, it had lost nearly half its mass and more than 40 points of purity, ending at 57%. A later degradation test of the same vendor’s retatrutide (test 555, a different 30 mg batch reconstituted in bacteriostatic water) held above 99.4% purity through 60 days.

We cannot diagnose the cause from one vial. A closure defect, contamination, or an unstable formulation could all explain it, and N = 1 cannot separate them. Of the eight refrigerated reconstituted vials here, seven held and one failed. That is why every result in this article carries a single-vial caveat.

One more note, because this result gets cited: it is a single vial out of eight. The other seven held, and the same vendor’s later batch (test 555) did not repeat it. We report every vial rather than a blended average, so nothing is smoothed over, and you can weigh the SSA result yourself: as a cautious worst-case number, or as an outlier to set aside, according to your own risk tolerance. What the full dataset does not support is a general rule that reconstituted retatrutide degrades quickly after 60 to 90 days.

The whole reconstituted picture

Every reconstituted condition above, from the recommended fridge-plus-BAC down to freezing, on one chart:

As a powder, it barely degrades

Everything above happens after reconstitution. Dry and sealed, the powder is a different story: two tests show it barely changes at all.

Test 625 re-tested three vendors’ lyophilized vials against their original baselines after a year or more in storage.

Unlike the reconstituted refrigerated tests above, these long-term vials were stored the way a researcher actually keeps them, not in a lab: sealed lyophilized powder in light-blocking peptide boxes, in an ordinary consumer refrigerator, for the full 14 to 21 months. That they held under normal household storage rather than lab-grade conditions makes the result more representative of real use, not less.

The mass figures even drift slightly upward, which can only be measurement variance. Here purity is the readout to trust: a sealed dry powder is not forming aggregates in solution, so any degradation would be chemical and would show as a purity drop. It did not; purity held flat across all three. After up to nearly two years, none showed meaningful degradation as a powder.

Test 293 looked at heat instead of time. It held vacuum-sealed vials of a QSC R15 product in a sous-vide bath at a constant 130 °F for 7, 14, and 21 days, against a refrigerated control from the same lot.

Mass did not move. Purity declined slowly and almost linearly, at roughly 0.15% per day of continuous heat. The note that came back from Janoshik, the lab that ran it, is worth quoting in full:

I exported the graph comparison between 0, 7, 14 and 21 days degradation of reta for you, because it is absolutely beautiful and so linear I cried a tear of wonder.

Peter Magic, Janoshik

Janoshik’s exported overlay (test 293): the four heat-exposure runs, day 0 through 21, nearly superimposed. This is the chromatogram behind the “beautifully linear” remark.

So a few weeks in a hot delivery truck is not what damages lyophilized retatrutide. Sealed and dry, the powder is the last thing to worry about; the clock only starts once you reconstitute.

Findings

Limitations

A few worth naming explicitly:

• Mostly N = 1 per condition. Most conditions rest on a single vial, which cannot separate a condition’s effect from vial-to-vial variability, as the SSA outlier shows.
• The study designs varied. Different intervals, products, and vendors, run at different times for different questions. They were never one unified experiment, so same-product comparisons (616 vs 624, the two arms of 683) are more reliable than cross-test ones.
• Mass and purity measure different things. Reported mass is total recovered peptide; purity is the fraction of that mass that elutes as intact peptide by HPLC. A vial can lose mass while purity holds (physical loss or adsorption) or hold mass while purity drops (chemical degradation), and the two sometimes diverge. Mass can also fall while purity holds for a procedural reason: labs typically filter the sample before each run to protect sensitive instruments, which removes aggregated or particulate material and lowers the recovered mass without changing the purity of what passes through.
• Measurement variance is real. As test 715’s bouncing purity readings show, single-point assay noise can run to several percent.
• Vendor and lot specificity. Results attach to the specific products and lots tested; other lots may differ.

Conclusion

Retatrutide is a durable compound with a few clear weak points. Once reconstituted, it stays stable for months in the fridge if it is mixed with real bacteriostatic water rather than ultrapure water; it degrades faster at room temperature, and freezing the solution does not help. As a dry, lyophilized powder it barely changes at all, whether over years of storage or weeks of sustained heat. Single-vial failures are rare but real, which is why any one result, including these, deserves caution.

The whole study, in one card

Every condition above, distilled into a single shareable summary, with the source and link baked in so it stands on its own wherever it ends up.

Downloads

References